Analysis questions the efficacy of statins in primary prevention

06/29/2010 | HealthDay News

A review of 11 studies showed that cholesterol-lowering statins did not lower mortality rates among patients at high risk of heart disease but without any prior history of the condition. The finding suggests "due consideration is needed in applying statin therapy in lower-risk primary prevention populations," the researchers said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC